Top compounds associated with response to MYO1H


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine gCSI pan-cancer AAC -0.16 0.002
mRNA bid1870 gCSI pan-cancer AAC -0.14 0.006
mRNA Irinotecan gCSI pan-cancer AAC -0.14 0.006
mRNA Doxorubicin gCSI pan-cancer AAC -0.12 0.02
mRNA Vorinostat gCSI pan-cancer AAC 0.099 0.05
mRNA thapsigargin gCSI pan-cancer AAC -0.075 0.2
mRNA Docetaxel gCSI pan-cancer AAC -0.064 0.2
mRNA paclitaxel gCSI pan-cancer AAC -0.057 0.3
mRNA MS-275 gCSI pan-cancer AAC 0.045 0.4
mRNA Erlotinib gCSI pan-cancer AAC -0.026 0.6
Download CSV